The pharmaceutical industry in Cambodia is currently undergoing a transformative phase. Traditionally dependent on imports from neighboring ASEAN countries and India, the Royal Government of Cambodia’s Pentagonal Strategy Phase I has prioritized the modernization of healthcare and the encouragement of local manufacturing. This shift has created an unprecedented demand for high-quality Active Pharmaceutical Ingredients (APIs) that meet international GMP (Good Manufacturing Practice) standards.
Currently, Cambodia’s pharmaceutical market is valued at approximately $400-500 million annually, with a compound annual growth rate (CAGR) of over 10%. While local production accounts for less than 20% of the market share, the expansion of special economic zones (SEZs) in Phnom Penh and Sihanoukville is attracting investment for pharmaceutical formulation plants. These plants require a reliable supply chain of raw materials—ranging from antibiotics like Oxytetracycline for the agricultural sector to anti-aging intermediates like NMNH for the growing wellness demographic.
Globally, the API industry is moving toward "Green Chemistry" and "Biotechnology-derived synthesis." As a leading manufacturer, Shanghai Aeterna Biotech bridges the gap between these global innovations and the Cambodian market. We understand that Cambodian distributors and manufacturers face unique logistical and regulatory challenges, and our "One-Stop Solution" approach is designed to mitigate these hurdles through localized expertise.
Shanghai Aeterna Biotech Co., Ltd. is a leading, reliable, and professional manufacturer specializing in fine chemicals, plant extracts, enzyme preparations, and nutritional ingredients. Our expertise spans research, development, production, and global sales. With decades of experience, we have built a solid reputation for delivering high-quality products and innovative solutions to a wide range of industries including pharmaceutical, nutraceutical, and cosmetic sectors.
Our facilities are equipped with state-of-the-art production and testing equipment, allowing us to meet the highest industry standards. Through years of serving European and American markets, our QA/QC team has gained extensive experience in impurity analysis, precise control of flavor and fragrance formulations, and rigorous quality management. Our commitment to safety and reliability ensures that every product meets the expectations of both clients and end consumers in the Cambodian market.
Physical & Chemical Testing
Moisture Detection
Assay Detection
HPLC Analysis
Looking toward 2030, Shanghai Aeterna Biotech is implementing a technical roadmap focused on Advanced Molecular Synthesis and Biosimilar Development. For the Cambodia market, we are prioritizing:
Our commitment to Cambodia is not merely transactional; it is a partnership. We aim to support the Kingdom's goal of becoming a pharmaceutical hub within the Greater Mekong Subregion by providing the raw materials that fuel industrial self-sufficiency.
Precision PH Analysis
Conductivity Control
Microbial Incubation
Sterilization Unit
Analytical Precision
Moisture Removal
Purity Testing
UV Spectrophotometry
Spectral Analysis
Thermostatic Control
Waters HPLC System
Heat Treatment
Heavy Metal Detection
Visual QC Unit
Aeterna Biotech
